(Total Views: 436)
Posted On: 08/06/2019 10:10:37 PM
Post# of 72447

Novartis subsidiary submits "incomplete" cherry-picked data to get FDA approval before it should have. FDA shrugs.
https://www.washingtonpost.com/health/2019/08...ency-says/
https://www.washingtonpost.com/health/2019/08...ency-says/

